Education
About Us
Working with TipRanks
Follow Us
Tenon Medical, Inc. (TNON)
NASDAQ:TNON
TNON Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.85 - $15.79
Previous CloseN/A
Volume74.29K
Average Volume (3M)9.21M
Market Cap
$12.43M
Enterprise Value$3.62M
Total Cash (Recent Filing)$7.85M
Total Debt (Recent Filing)$290.00K
Price to Earnings (P/E)―
Beta1.45
Next Earnings
Nov 12, 2025EPS Estimate
-0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding8,879,220
10 Day Avg. Volume2,972,114
30 Day Avg. Volume9,205,432
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.29
Enterprise Value/Revenue1.23
Enterprise Value/Gross Profit2.70
Enterprise Value/Ebitda-0.29
Forecast
1Y Price Target
$1.50Price Target Upside0.67% Upside
Rating ConsensusHold
Number of Analyst Covering0
Bulls Say, Bears Say
Bulls Say
Market OpportunityTNON's Catamaran SI Joint Fusion System received an expanded indication from the FDA for use in augmenting thoracolumbar fusion, significantly increasing the company’s total addressable market and potentially accelerating adoption.
Product PotentialDespite sluggish year-over-year growth, there is a bullish view on the potential of the Catamaran System as a superior option in SI-joint fusion.
ValuationWith a significant market opportunity and superior technology, TNON is considered undervalued, supporting a Buy rating.
Bears Say
Reimbursement ChallengesReimbursement uncertainty remains a key risk, leading to lower revenue estimates and a reduced price target.
Revenue ExpectationsRevenue fell slightly short of expectations due to ongoing reimbursement preapproval challenges for Sacroiliac Joint fusion surgery.
Revenue PerformanceTNON’s revenue growth was relatively flat year-over-year due to continued reimbursement related headwinds.
Tenon Medical, Inc. News
TNON FAQ
What was Tenon Medical, Inc.’s price range in the past 12 months?
Tenon Medical, Inc. lowest stock price was $0.85 and its highest was $15.79 in the past 12 months.
What is Tenon Medical, Inc.’s market cap?
Tenon Medical, Inc.’s market cap is $12.43M.
When is Tenon Medical, Inc.’s upcoming earnings report date?
Tenon Medical, Inc.’s upcoming earnings report date is Nov 12, 2025 which is in 81 days.
How were Tenon Medical, Inc.’s earnings last quarter?
Tenon Medical, Inc. released its earnings results on Aug 13, 2025. The company reported -$0.36 earnings per share for the quarter, beating the consensus estimate of -$0.47 by $0.11.
Is Tenon Medical, Inc. overvalued?
According to Wall Street analysts Tenon Medical, Inc.’s price is currently Undervalued.
Does Tenon Medical, Inc. pay dividends?
Tenon Medical, Inc. does not currently pay dividends.
What is Tenon Medical, Inc.’s EPS estimate?
Tenon Medical, Inc.’s EPS estimate is -0.4.
How many shares outstanding does Tenon Medical, Inc. have?
Tenon Medical, Inc. has 8,879,220 shares outstanding.
What happened to Tenon Medical, Inc.’s price movement after its last earnings report?
Tenon Medical, Inc. reported an EPS of -$0.36 in its last earnings report, beating expectations of -$0.47. Following the earnings report the stock price went down -16.168%.
Which hedge fund is a major shareholder of Tenon Medical, Inc.?
Currently, no hedge funds are holding shares in TNON
Company Description
Tenon Medical, Inc.
Tenon Medical, Inc. (TNON) is a medical technology company that operates in the healthcare sector, focusing on the development and commercialization of surgical implant systems. The company specializes in providing innovative solutions for the sacroiliac joint fusion market, offering products designed to improve surgical outcomes and patient recovery times. Their core product is a surgical implant system that assists in the stabilization and fusion of the sacroiliac joint, a common source of lower back pain.
TNON Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a strategic focus on growth through acquisition and product development, with significant financial discipline and an improved cash position. However, the company experienced a decline in revenue and gross profit, contributing to a net loss.View all TNON earnings summariesTechnical Analysis
Sintx Technologies
―
Biomerica
―
Aethlon Medical
―
Venus Concept
―
Autonomix Medical, Inc.
―
Ownership Overview
―
Insiders
0.30% Mutual Funds
0.34% Other Institutional Investors
99.27% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---